Interim report for the third quarter 2020, January 1st – September 30th, 2020

by | Nov 20, 2020

Third quarter in brief as well as the period 1 January – 30 September 2020Net sales for the period (January to September) amounted to SEK 0,09 million (3,3 million), of which the third quarter contributed SEK 0,05 million (0,20 million).R&D costs for the period...

Delårsrapport för tredje kvartalet 2020, 1 januari – 30 september 2020

by | Nov 20, 2020

Tredje kvartalet i korthet samt perioden 1 januari – 30 september 2020Nettoomsättningen för perioden (januari till september) uppgick till 0,09 Mkr (3,3 Mkr), varav tredje kvartalet utgjorde 0,05 Mkr (0,20 Mkr).FoU-kostnader för perioden uppgick till 28,1 Mkr (27,5...

Interim report for the third quarter 2019, 1 January – 30 September 2019

by kancerawebedit | Nov 26, 2019

Third quarter in brief 1 July – 30 September 2019 Net sales for the period (January to September) amounted to SEK 3,3 Million (0,1 Million) of which the third quarter contributed SEK 0,2 Million (0,0 Million). R&D costs for the period amounted to SEK 27,5 Million...

Delårsrapport för tredje kvartalet 2019, 1 januari – 30 september 2019

by kancerawebedit | Nov 22, 2019

Tredje kvartalet i korthet 1 juli – 30 september 2019 Nettoomsättning för perioden (januari till september) uppgick till 3,3 Mkr (0,1 Mkr) varav tredje kvartalet utgjorde 0,2 Mkr (0,0 Mkr). FoU-kostnader för perioden uppgick till 27,5 Mkr (31,3 Mkr) varav tredje...

INTERIM REPORT FOR KANCERA  AB (publ) 1st January – 30th September 2018

by kancerawebedit | Nov 23, 2018

PERIOD JAN – SEPTEMBER 2018, AND THIRD QUARTER IN BRIEF • Net sales for the period (January to September) amounted to SEK 0.1 million (SEK 0.1 million) of which the third quarter amounted to SEK 0.1 million (SEK 0.0 million). • R&D expenses for the period...